Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea | IC50 | 4.0 [1] | |
| N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea | Ki | 1.58 [1], 1.8 [2], 2.95 [3] | |
| Sincalide | Ki | 0.28 [1], 0.3 [2], 0.64 [3], 0.65 [4] | |
| Devazepide | IC50 | 245.0 [1] | |
| Devazepide | Ki | 3.69 [1], 29.51 [2], 51.29 [3], 62.0 [4], 87.1 [5] | |
MLA | "Quest Database™ Cholecystokinin B receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 13 Dec. 2025, https://www.aatbio.com/data-sets/cholecystokinin-b-receptor-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 13). Quest Database™ Cholecystokinin B receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cholecystokinin-b-receptor-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |